Sandostatin 0
Sandostatin 0 is a medicine authorised by Swissmedic under authorisation number 49137. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 August 1988 and the authorisation is valid without a time limit. ATC code H01CB02 places the medicine in the group Pituitary and hypothalamic hormones and analogues.
| Authorisation number | 49137 |
|---|---|
| Name | Sandostatin 0 |
| Full name | Sandostatin 0,05 mg/mL, Injektionslösung |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | H01CB02 |
| First authorisation | 15 August 1988 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sandostatin 0,05 mg/mL, Injektionslösung | A | 15 August 1988 |
| 2 | Sandostatin 0,1 mg/mL, Injektionslösung | A | 15 August 1988 |
| 4 | Sandostatin 0,5 mg/mL, Injektionslösung | A | 22 March 1991 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 28 | 5 x 1 ml | Ampulle(n) | H01CB02 | 07.16.2. | A |
| 44 | 5 x 1 ml | Ampulle(n) | H01CB02 | 07.16.2. | A |
| 79 | 5 x 1 ml | Ampulle(n) | H01CB02 | 07.16.2. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sandostatin 0 authorised in Switzerland?
Yes. Sandostatin 0 is authorised by Swissmedic under authorisation number 49137, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sandostatin 0 have?
Sandostatin 0 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Sandostatin 0?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.